Proper labeling prevents accidental mix-ups between different concentration vials
doi:10.1016/j.bcp.2024.116476 Evidence-Base Disclosure The published evidence base for 5-Amino-1MQ consists predominantly of preclinical research animal models (often rats or mice) and in vitro cell-culture experiments
Clinical consultation Review diagnostic labs and a personalized plan
Based on our review of the available research, doses of 1-2 mg per day of reconstituted injectable GHK-Cu offer numerous therapeutic benefits in test subjects including anti-inflammatory action, tissue repair, hair growth, and more
Bone research benefits from the ability of GHK-Cu to stimulate BMP-2 (bone morphogenetic protein 2)
The funders had no role in the design of the study, in the collection, analysis, and interpretation of data, or in writing the manuscript